IBOV 178,721.76 ▲ 0.73% IPSA 11,315.26 ▼ 1.14% IPC MEX 65,430.32 ▼ 0.08% MERVAL 3,070,880 ▲ 1.22% COLCAP 2,467.03 ▲ 1.73% BVL PERÚ 59,450.29 ▲ 0.04% USD/BRL5.15▼ 0.74% USD/MXN16.95▼ 0.26% USD/CLP936.56▲ 0.25% USD/COP3,176▼ 0.79% USD/PEN3.36▼ 0.10% USD/ARS1,512▲ 0.22% USD/UYU40.24▲ 0.68% USD/PYG5,873▲ 0.47% USD/BOB12.08▲ 3.98% USD/DOP58.56▲ 0.38% USD/CRC446.47▲ 1.09% USD/GTQ7.62▲ 1.63% USD/HNL26.84▲ 1.11% USD/NIO36.62▲ 0.14% USD/VES796.33▼ 0.13% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD 157.28 — 0.00% USD/TTD6.69▼ 0.06% EUR/BRL5.96▼ 0.76% BRENT 88.88 ▼ 0.03% WTI 83.11 ▼ 0.11% IRON ORE 161.91 — — COPPER 6.61 ▲ 0.03% GOLD 4,461 ▲ 1.78% SILVER 65.59 ▲ 1.26% SOY 1,184 ▲ 3.20% CORN 480.50 ▲ 10.02% WHEAT 655.00 ▲ 3.93% COFFEE 317.25 ▼ 5.51% SUGAR 16.43 ▼ 1.79% ORANGE JUICE 138.55 ▼ 0.47% COTTON 85.03 ▲ 2.33% COCOA 5,719 ▲ 3.18% BEEF 223.60 ▼ 3.93% CATTLE 339.10 ▼ 3.16% LITHIUM 75.20 ▲ 1.47% PETR4 41.64 ▼ 0.05% VALE3 72.97 ▲ 0.83% ITUB4 38.60 ▼ 1.03% BBDC4 16.85 ▲ 0.36% ABEV3 14.89 ▼ 0.80% BBAS3 19.37 ▲ 0.47% B3SA3 14.26 ▼ 0.21% WEGE3 47.59 ▲ 0.49% PRIO3 59.14 ▼ 0.19% SUZB3 41.33 ▲ 2.35% RENT3 34.68 ▼ 0.09% AZZA3 15.89 ▼ 2.63% CSAN3 3.22 ▼ 1.83% RAIZ4 0.25 — 0.00% PCAR3 2.75 ▼ 0.36% GMAT3 3.65 ▼ 1.08% PSSA3 48.13 ▼ 0.54% CVCB3 1.33 ▼ 2.92% POSI3 3.36 ▲ 2.44% SLCE3 13.34 ▲ 0.30% NATU3 8.14 ▼ 0.73% IBOV 178,721.76 ▲ 0.73% IPSA 11,315.26 ▼ 1.14% IPC MEX 65,430.32 ▼ 0.08% MERVAL 3,070,880 ▲ 1.22% COLCAP 2,467.03 ▲ 1.73% BVL PERÚ 59,450.29 ▲ 0.04% USD/BRL 5.16 ▲ 0.01% USD/MXN 17.06 ▼ 0.24% USD/CLP 913.98 ▲ 0.04% USD/COP 3,140 ▲ 0.03% USD/PEN 3.36 ▼ 0.66% USD/ARS 1,493 ▲ 0.10% USD/UYU 40.27 ▲ 1.24% USD/PYG 5,939 ▲ 1.68% USD/BOB 11.64 ▼ 0.76% USD/DOP 58.34 ▲ 1.25% USD/CRC 445.92 ▲ 0.89% USD/GTQ 7.62 ▲ 2.21% USD/HNL 26.79 ▲ 1.57% USD/NIO 36.62 ▲ 0.69% USD/VES 762.44 ▼ 0.13% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.28 — 0.00% USD/TTD 6.70 ▲ 0.61% EUR/BRL 5.95 ▲ 1.01% BRENT 88.88 ▼ 0.03% WTI 83.11 ▼ 0.11% IRON ORE 161.91 — — COPPER 6.61 ▲ 0.03% GOLD 4,461 ▲ 1.78% SILVER 65.59 ▲ 1.26% SOY 1,184 ▲ 3.20% CORN 480.50 ▲ 10.02% WHEAT 655.00 ▲ 3.93% COFFEE 317.25 ▼ 5.51% SUGAR 16.43 ▼ 1.79% ORANGE JUICE 138.55 ▼ 0.47% COTTON 85.03 ▲ 2.33% COCOA 5,719 ▲ 3.18% BEEF 223.60 ▼ 3.93% CATTLE 339.10 ▼ 3.16% LITHIUM 75.20 ▲ 1.47% PETR4 41.64 ▼ 0.05% VALE3 72.97 ▲ 0.83% ITUB4 38.60 ▼ 1.03% BBDC4 16.85 ▲ 0.36% ABEV3 14.89 ▼ 0.80% BBAS3 19.37 ▲ 0.47% B3SA3 14.26 ▼ 0.21% WEGE3 47.59 ▲ 0.49% PRIO3 59.14 ▼ 0.19% SUZB3 41.33 ▲ 2.35% RENT3 34.68 ▼ 0.09% AZZA3 15.89 ▼ 2.63% CSAN3 3.22 ▼ 1.83% RAIZ4 0.25 — 0.00% PCAR3 2.75 ▼ 0.36% GMAT3 3.65 ▼ 1.08% PSSA3 48.13 ▼ 0.54% CVCB3 1.33 ▼ 2.92% POSI3 3.36 ▲ 2.44% SLCE3 13.34 ▲ 0.30% NATU3 8.14 ▼ 0.73%
since 2009
Tuesday, September 1, 2026

Brazil Life & Society

Brazilian Minister Does not Like Result of Drug Study and Attacks Authors

By · May 29, 2019 · 2 min read

Daily Brief

The morning intel from across Latin America. Free.

By subscribing you agree to our privacy policy. We never share your email.

By Xiu Ying, Contributing Reporter

RIO DE JANEIRO, BRAZIL – From 2014 to 2017, the Oswaldo Cruz Foundation (Fiocruz) conducted 16,000 interviews and assigned 500 researchers to develop the Third National Survey on Drug Use by the Brazilian Population.

The veto on this edition's publication surprised the scientific community.
Osmar Terra’s veto on this edition’s publication surprised the scientific community. (Photo Internet reproduction)
One-stop reference
Company Intelligence
Every listed company in Latin America — financials, ownership and structure for 1,450+ companies across 26 exchanges, in one place.
Browse the directory →
RT
Ask Rio Times
This story and the bigger picture.
Open the full Ask Rio Times →

It is a sort of census on the consumption of licit and illicit substances in Brazil.

Given its scope, the study was expensive: R$7 (US$1.75) million, paid by the government, which has now shelved the research, preventing Fiocruz from disclosing it.

The foundation won the call for tenders to carry out the study in 2014, having won bids for the two previous surveys.

The prohibition against this edition’s publication surprised the scientific community.

The veto is permissible – a clause in the contract stipulates that research may only be disclosed with the consent of the National Secretariat of Drug Policy (Senad), an agency linked to the Ministry of Justice.

For researchers and specialists in the field, however, the study has been shelved for a different reason: it does not confirm the existence of a drug epidemic in the country, as Osmar Terra, the Minister of Citizenship, often proclaims exists.

Senad officially claims that the survey has not been released because Fiocruz failed to comply with the requirements of the public bid procedure. On the other hand, the Minister seems to confirm what experts suspect by attacking the institution and claiming that the survey does not corroborate what is seen “on the streets”.

Read More from The Rio Times

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.